SCHIP/45/01 rev 2
Meeting at 10.45 am, Wednesday 21 November 2001
Globe Room, Rose Court, London
Preliminaries:
1. Introductions/apologies
2. Adoption of agenda
3. SCHIP Secretariat Report (SCHIP/47/01 rev 1) - adoption
ACTION: The Secretariat to make enquiries on the publication status of a draft article for Contact Dermatitis
For discussion and formal endorsement by SCHIP:
4. CHIP 3 transitional arrangements (SCHIP/57/01)
5. Negotiation of supply classification and labelling directives (SCHIP/54/01)
ACTION: The Secretariat to place SCHIP/08/96 and SCHIP/09/96 on the SCHIP website
6. SCHIP and its panels (SCHIP/51/01)
ACTION: The Secretariat to issue a paper describing the agreed subgroup arrangements and inviting Members to formally indicate their interest in serving on the subgroups
For information and discussion:
7. SCHIP and openness - Register of Interests
Oral reports:
8. Report on C&L Working Group meeting at ECB on 5-7 September 2001 (SCHIP/49/01)
9. CHIP 3 update
ACTION: The Secretariat to send, by no later than 5 December, a draft of the new edition of the guidance publication CHIP for everyone to Members for comments (and drafts of the leaflets: Why do I need a safety data sheet? and Read the label) soon after
10. EC Chemical Review update (SCHIP/50/01)
ACTION: The Secretariat to send Members an
electronic copy of the Chemical Review presentation11. Proposed date and venue for next meeting - Rose Court [date]
ACTION: The Secretariat to see if 21 May possible and then to settle a date for the next meeting of SCHIP
SCHIP Secretariat
26 November 2001
ANNEX
Papers for SCHIP - 24 May 2001 to 21 November 2001
SCHIP/29/01 | Information to SCHIP: 11 June 2001 |
SCHIP/18/00 rev 3 | SCHIP update: current awareness |
SCHIP/19/00 rev 2 | SCHIP update: current UK proposals for changes to the annexes of the Dangerous Substances Directive (67/548/EEC) |
SCHIP/30/01 | SCHIP 23 May 2001: report of meeting |
SCHIP/31/01 | Labelling phrase for preparations containing a sensitising substance |
SCHIP/32/01 | Information to SCHIP: 27 June 2001 |
Appendix 1 | 2,4'-diaminoanisole (and sulphate): UK proposal |
Appendix 2 | Chemical Review rapid response panel: update on progress |
SCHIP/18/00 rev 4 | SCHIP update: current awareness |
SCHIP/33/01 | Information to SCHIP: 29 June 2001 |
Appendix 1a | Letter from ECB dated 28 June 2001 covering 3 draft test methods |
Appendix 1b | Draft revised test method B4 (acute toxicity: dermal irritation/corrosion) |
Appendix 1c | Draft revised test method B5 (acute toxicity: eye irritation/corrosion) |
Appendix 1d | Draft new test method B42 (skin sensitisation: local lymph node assay) |
SCHIP/34/01 | Summary report of 27th test methods coordinators meeting |
SCHIP/35/01 | Information to SCHIP: 18 July 2001 |
Appendix 1 | 1st ATP to Dangerous Preparations Directive |
Appendix 2 | 2nd Amendment to Safety Data Sheets Directive |
SCHIP/36/01 | Message to SCHIP Members from SCHIP Chair |
SCHIP/37/01 | Information to SCHIP: 26 July 2001 |
SCHIP/38/01 | Report of CMR Working Group meeting: Ispra 30 May – 1 June 2001 |
SCHIP/39/01 | Table of substances under review for Annex I to 67/548/EEC: situation at June 2001 |
SCHIP/40/01 | Information to SCHIP: 20 August 2001 |
Appendix 1a | ECBI/01/04 add 4 – 1-ethoxypropan-2-ol classification proposal |
Appendix 1b | ECBI/01/04 add 5 – TEGBE: eye irritation and skin defatting |
Appendix 2 | ECBI/05/01 – aerosols: inhalation toxicity criteria |
Appendix 3a | ECBI/12/97 add 14 – CMS wools: classification proposal |
Appendix 3b | ECBI/12/97 add 15 – CMS wools: biopersistence after short term exposure by inhalation |
Appendix 3c | ECBI/12/97 add 16 – CMS wools: short term inhalation study |
Appendix 3d | ECBI/12/97 add 17 – CMS wools: subchronic inhalation study |
Appendix 3e | ECBI/12/97 add 17 – CMS wools: subchronic inhalation study – appendix 1 |
Appendix 3f | ECBI/12/97 add 18 – CMS wools: biopersistence following intratracheal instillation |
Appendix 3f | ECBI/12/97 add 19 - CMS wools: biopersistence following intratracheal instillation |
Appendix 3g | ECBI/12/97 add 20 – CMS wools: biopersistence following intratracheal instillation |
Appendix 4a | ECBI/22/01 add 2 – MDI: carcinogenicity |
Appendix 4b | ECBI/22/01 add 3 – MDI: carcinogenicity |
Appendix 5a | ECBI/23/01 add 1 rev 1 – phenol: specific concentration limits |
Appendix 5b | ECBI/23/01 add 2 – phenol: mutagenicity |
Appendix 6 | ECBI/24/01 add 1 – but-2-yne-1,4-diol: classification proposal revision |
Appendix 7 | ECBI/25/01 add 1 – cadmium sulphide: summary of classification proposal |
Appendix 8a | ECBI/35/01 – octamer: concentration limit for elicitation of skin sensitisation |
Appendix 8b | ECBI/35/01 add 1 – octamer: concentration limit for elicitation of skin sensitisation |
Appendix 9a | ECBI/36/01 add 4 – bisphenol A: reproductive toxicity data |
Appendix 9b | ECBI/36/01 add 5 – bisphenol A: reproductive toxicity, fertility assessment |
Appendix 9c | ECBI/36/01 add 6 – bisphenol A: article on perinatal exposure to low doses |
Appendix 9d | ECBI/36/01 add 7 – bisphenol A: article on in utero exposure in mice |
Appendix 9e | ECBI/36/01 add 7 – bisphenol A: continuation of app 9d |
Appendix 9f | ECBI/36/01 add 8 – bisphenol A: article |
Appendix 9g | ECBI/36/01 add 8 – bisphenol A: continuation of app 9f |
Appendix 9h | ECBI/36/01 add 9 – bisphenol A: letter from Sweden |
Appendix 10a | ECBI/37/99 add 27 – benzyl butyl phthalate: letter from ECPI |
Appendix 10b | ECBI/37/99 add 27 – benzyl butyl phthalate: result of studies |
Appendix 10c | ECBI/37/99 add 29 – benzyl butyl phthalate: letter from ECPI |
Appendix 10d | ECBI/37/99 add 29 – benzyl butyl phthalate: letter from ECPI |
Appendix 10e | ECBI/37/99 add 30 – benzyl butyl phthalate: classification for developmental toxicity |
Appendix 10f | ECBI/37/99 add 31 – benzyl butyl phthalate: biomarker approach to measuring human dietary exposure |
Appendix 11 | ECBI/44/01 rev 1 – CMR meeting on 5-7 September 2001: draft agenda |
Appendix 12 | ECBI/45/99 add 25 – hydrogen peroxide: vapour concentrations |
Appendix 13 | ECBI/48/01 – 1,1,2-trichloroethane: revised rationale for classification |
Appendix 14 | ECBI/49/01 – N,N,N',N'-tetramethyl-4,4'-methylenedianiline: classification proposal from Germany |
Appendix 15 | ECBI/50/01 – 2-ethylhexyl acrylate: classification proposal |
Appendix 16 | ECBI/51/01 – 1,2-benzenedicarboxylic acid, di-C7-C9-branched and linear alkylesters di-C7-C9 phthalate (slightly branched): rationale for classification |
Appendix 17 | ECBI/52/01 – 1,2-benzenedicarboxylic acid, di-C7-C11-branched and linear alkylesters di-C7-C11 phthalate (highly branched): rationale for classification |
Appendix 18 | ECBI/53/01 – 1,2-benzenedicarboxylic acid, di-C9-C11-branched and linear alkylesters di-C9-C11 phthalate (slightly branched): rationale for classification |
Appendix 19 | ECBI/54/01 – GHS: decision logic |
Appendix 20 | ECBI/55/01 add 3 – sulphuryl difluoride: respiratory irritation |
Appendix 21a | ECBI/59/98 add 11 – CI Basic Violet: chronic toxicity/carcinogenicity studies |
Appendix 21b | ECBI/59/98 add 12 - CI Basic Violet: chronic toxicity/carcinogenicity studies |
Appendix 21c | ECBI/59/98 add 12 – CI Basic Violet: continuation of app 21b |
Appendix 22 | ECBI/64/00 add 3 – aniline: note from CEFIC |
Appendix 23 | ECBI/65/00 add 7 – o-nitrotoluene: toxicology and carcinogenesis studies |
Appendix 24 | ECBI/67/00 add 1 – criteria for application of R48: note from CEFIC |
Appendix 25 | ECBI/76/00 rev 2 – CMR meeting 15-17 November 2000: draft summary record |
SCHIP/41/01 | Information to SCHIP: 18 October 2001 |
SCHIP/42/01 | SCHIP Induction Day 10 September: report of meeting |
SCHIP/43/01 | CHIP and downstream legislation |
SCHIP/44/01 | CHIP and the environment |
SCHIP/45/01 | Draft agenda for SCHIP meeting on 21 November 2001 |
SCHIP/46/01 | Information to SCHIP: 24 October 2001 |
SCHIP/18/00 rev 4 | SCHIP update: current awareness |
SCHIP/47/01 | Secretariat Report to the meeting on 21 November 2001 |
SCHIP/48/01 | Briefing for electronic COSHH Essentials |
SCHIP/49/01 | Report of discussions in CMR Working Group – 7 September 2001 |
SCHIP/50/01 | EC Chemicals Review – an update |
SCHIP/51/01 | SCHIP working arrangements: panels |
SCHIP/52/01 | Information to SCHIP: 1 November 2001 |
SCHIP/53/01 | Technical information note: potency of carcinogens |
SCHIP/54/01 | EU discussions on classification and labelling issues: working approaches to negotiations |
SCHIP/55/01 | n-propyl bromide: draft UK classification and labelling proposal |
SCHIP/56/01 | Information to SCHIP: 6 November 2001 |
SCHIP/57/01 | CHIP 3 – transition |
SCHIP/58/01 | Information to SCHIP: 15 November 2001 |
SCHIP/59/01 | Methyl chloroformate: UK classification and labelling proposal |
SCHIP/60/01 | Methyl isocyanate: UK classification and labelling proposal |
SCHIP/61/01 | Information to SCHIP: 22 November 2001 |
SCHIP/62/01 | Five chromium (VI) salts: UK classification and labelling proposals (for health effects only) |
SCHIP/63/01 | Chromium (VI) trioxide: UK classification and labelling proposal (for health effects only) |
SCHIP/08/96 | The UK's practical approach to EU negotiations on proposals for the classification of dangerous substances |
SCHIP/09/96 | Negotiations on classification and labelling issues in Commission Working Groups – the basic principles of the UK approach |
SCHIP/45/01 rev 1 | SCHIP meeting on 21 November 2001: agenda |
SCHIP/47/01 rev 1 | SCHIP meeting on 21 November 2001: Secretariat Report |
First published on the HSE web site 23 October 2001; decisions added 5 December 2001